Millington Financial Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.19M Buy
26,468
+441
+2% +$42.2K 0.92% 34
2025
Q4
$2.68M Buy
26,027
+1,190
+5% +$116K 1.19% 26
2025
Q3
$2.37M Buy
24,837
+714
+3% +$65.6K 1.15% 29
2025
Q2
$2.22M Buy
24,123
+1,220
+5% +$103K 1.12% 31
2025
Q1
$1.9M Buy
22,903
+1,447
+7% +$129K 1.17% 25
2024
Q4
$1.94M Buy
21,456
+1,828
+9% +$158K 1.13% 26
2024
Q3
$1.77M Buy
19,628
+623
+3% +$52.4K 1.1% 31
2024
Q2
$1.5M Buy
19,005
+324
+2% +$26.6K 1.04% 33
2024
Q1
$1.63M Buy
18,681
+802
+4% +$68.4K 1.16% 26
2023
Q4
$1.47M Buy
+17,879
New +$1.36M 1.18% 27

Other funds holding MDT

Millington Financial Advisors's MDT Position: Q1 2026 in Review

Millington Financial Advisors increased its Medtronic (MDT) stake by 1.7% in Q1 2026, buying an estimated $42.2K and bringing the position to 26,468 shares worth $2.19M. The position accounts for 0.92% of the portfolio, ranked #34.

Millington Financial Advisors first reported a position in MDT in Q4 2023 and has held it in 10 quarters since. The position peaked at $2.68M in Q4 2025. 2,230 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Millington Financial Advisors held 26,468 shares of Medtronic worth $2.19M as of Q1 2026.
  • Millington Financial Advisors bought 441 Medtronic shares in Q1 2026, an estimated $42.2K.
  • Medtronic made up 0.92% of Millington Financial Advisors's portfolio in Q1 2026, its #34 holding.
  • Millington Financial Advisors first reported a position in Medtronic in Q4 2023 and has held it in 10 quarters since.
  • Millington Financial Advisors's Medtronic position peaked at $2.68M in Q4 2025.
  • 2,230 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Millington Financial Advisors's 13F filing for Q1 2026, filed 8 May 2026.